2025-02-19 IDOPRESS

BARCELONA,Spain,Feb. 17,2025 --Global technology brand HONOR today announced that it will unveilits new strategic initiative,the"HONOR ALPHA PLAN",at Mobile World Congress (MWC) 2025and showcase its latest AI innovations.

The term "ALPHA" carries profound significance across multiple dimensions. It symbolizes a pioneering spirit in exploration,represents excellence at the highest level,and stands for exceptional performance through innovation and strategic foresight. The HONOR ALPHA PLAN embodies these core values as the company's new strategic direction.
Through this initiative,HONOR is committed to fostering an open and collaborative environment where innovation thrives through partnership. By leveraging its technological expertise and working closely with global partners,HONOR aims to build a robust AI ecosystem that pushes the boundaries of what is possible.
The keynote presentation will take place in Barcelona at 4:30 PM CET on March 2,2025. For all upcoming announcements and updates ahead of MWC 2025,please visit https://www.honor.com/global/events/honor-mwc/ .
About HONOR
HONOR is a leading global provider of smart devices. It is dedicated to becoming a global iconic technology brand and creating a new intelligent world for everyone through its powerful products and services. With an unwavering focus on R&D,it is committed to developing technology that empowers people around the globe to go beyond,giving them the freedom to achieve and do more. Offering a range of high-quality smartphones,tablets,laptops and wearables to suit every budget,HONOR's portfolio of innovative,premium and reliable products enable people to become a better version of themselves.
For more information,please visit HONOR online at www.honor.com.
https://www.honor.com/global/club/
https://www.facebook.com/honorglobal/
https://twitter.com/Honorglobal
https://www.instagram.com/honorglobal/
https://www.youtube.com/c/HonorOfficial
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map